PL1765355T3 - Benzoksazyny do leczenia schorzeń dróg oddechowych - Google Patents

Benzoksazyny do leczenia schorzeń dróg oddechowych

Info

Publication number
PL1765355T3
PL1765355T3 PL05740045T PL05740045T PL1765355T3 PL 1765355 T3 PL1765355 T3 PL 1765355T3 PL 05740045 T PL05740045 T PL 05740045T PL 05740045 T PL05740045 T PL 05740045T PL 1765355 T3 PL1765355 T3 PL 1765355T3
Authority
PL
Poland
Prior art keywords
benzoxazine
respiratory tract
treating respiratory
tract diseases
diseases
Prior art date
Application number
PL05740045T
Other languages
English (en)
Inventor
Thierry Bouyssou
Ingo Konetzki
Sabine Pestel
Andreas Schnapp
Christoph Hoenke
Philipp Lustenberger
Klaus Rudolf
Kurt Schromm
Frank Buettner
Claudia Heine
Hermann Schollenberger
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of PL1765355T3 publication Critical patent/PL1765355T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PL05740045T 2004-04-22 2005-04-18 Benzoksazyny do leczenia schorzeń dróg oddechowych PL1765355T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004019539A DE102004019539A1 (de) 2004-04-22 2004-04-22 Neue Arzneimittel zur Behandlung von Atemwegserkrankungen
EP05740045A EP1765355B1 (de) 2004-04-22 2005-04-18 Benzoxazine zur behandlung von atemwegserkrankungen
PCT/EP2005/004075 WO2005102350A1 (de) 2004-04-22 2005-04-18 Benzoxazine zur behandlung von atemwegserkrankungen

Publications (1)

Publication Number Publication Date
PL1765355T3 true PL1765355T3 (pl) 2013-08-30

Family

ID=34966948

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05740045T PL1765355T3 (pl) 2004-04-22 2005-04-18 Benzoksazyny do leczenia schorzeń dróg oddechowych

Country Status (20)

Country Link
EP (1) EP1765355B1 (pl)
JP (1) JP2007533684A (pl)
KR (2) KR20130042662A (pl)
CN (1) CN1946406A (pl)
AU (1) AU2005235420C1 (pl)
BR (1) BRPI0510084A (pl)
CA (1) CA2559700C (pl)
DE (1) DE102004019539A1 (pl)
DK (1) DK1765355T3 (pl)
EA (1) EA012045B1 (pl)
EC (1) ECSP066948A (pl)
ES (1) ES2403184T3 (pl)
IL (1) IL177663A (pl)
NO (1) NO20065061L (pl)
NZ (1) NZ551272A (pl)
PL (1) PL1765355T3 (pl)
SG (1) SG152233A1 (pl)
UA (1) UA85707C2 (pl)
WO (1) WO2005102350A1 (pl)
ZA (1) ZA200606547B (pl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
DE102004024452A1 (de) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation von Betaagonisten
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
EP1917253B1 (de) 2005-08-15 2015-01-07 Boehringer Ingelheim International Gmbh Verfahren zur herstellung von betamimetika
KR20080067699A (ko) * 2005-11-09 2008-07-21 베링거 인겔하임 인터내셔날 게엠베하 흡입용 에어로졸 제형
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
JP5584138B2 (ja) 2008-01-11 2014-09-03 ノバルティス アーゲー キナーゼ阻害剤としてのピリミジン類
WO2012034095A1 (en) 2010-09-09 2012-03-15 Irm Llc Compounds and compositions as trk inhibitors
UY33597A (es) 2010-09-09 2012-04-30 Irm Llc Compuestos y composiciones como inhibidores de la trk
BR112013021638A2 (pt) 2011-02-25 2016-08-02 Irm Llc "compostos inibidores de trk, seu uso e composições que os compreendem"
US9784726B2 (en) 2013-01-08 2017-10-10 Atrogi Ab Screening method, a kit, a method of treatment and a compound for use in a method of treatment
CN110062625A (zh) 2016-12-12 2019-07-26 勃林格殷格翰国际有限公司 尼达尼布通过与奥达特罗共给予用于治疗间质性肺病的方法
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201903832D0 (en) 2019-03-20 2019-05-01 Atrogi Ab New compounds and methods
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses
CN120583945A (zh) 2023-01-20 2025-09-02 阿托基公司 用于治疗或预防肌肉消耗的β2-肾上腺素能受体激动剂
GB202302225D0 (en) 2023-02-16 2023-04-05 Atrogi Ab New medical uses
GB202303229D0 (en) 2023-03-06 2023-04-19 Atrogi Ab New medical uses
GB202403169D0 (en) 2024-03-05 2024-04-17 Atrogi Ab New medical uses
WO2025238248A1 (en) 2024-05-17 2025-11-20 Atrogi Ab USE OF β2-ADRENERGIC RECEPTOR AGONISTS IN TREATING MUSCLE WASTING

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460581A (en) 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
HUP0300832A2 (hu) * 2000-04-27 2003-08-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Új, lassú hatású bétamimetikumok, eljárás előállításukra és alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
DE10253282A1 (de) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung

Also Published As

Publication number Publication date
CA2559700C (en) 2013-06-11
EA012045B1 (ru) 2009-08-28
ZA200606547B (en) 2008-04-30
SG152233A1 (en) 2009-05-29
NO20065061L (no) 2006-11-07
WO2005102350A1 (de) 2005-11-03
KR101338947B1 (ko) 2013-12-10
DK1765355T3 (da) 2013-04-08
CA2559700A1 (en) 2005-11-03
IL177663A (en) 2014-04-30
KR20070054599A (ko) 2007-05-29
AU2005235420C1 (en) 2011-02-24
EP1765355A1 (de) 2007-03-28
KR20130042662A (ko) 2013-04-26
JP2007533684A (ja) 2007-11-22
ECSP066948A (es) 2006-12-20
IL177663A0 (en) 2006-12-31
AU2005235420B2 (en) 2010-10-28
DE102004019539A1 (de) 2005-11-10
NZ551272A (en) 2010-10-29
UA85707C2 (ru) 2009-02-25
EP1765355B1 (de) 2013-03-06
EA200601837A1 (ru) 2007-04-27
CN1946406A (zh) 2007-04-11
AU2005235420A1 (en) 2005-11-03
BRPI0510084A (pt) 2007-10-16
ES2403184T3 (es) 2013-05-16

Similar Documents

Publication Publication Date Title
IL177663A0 (en) Benzoxazine for treating respiratory tract diseases
IL226562A0 (en) Pharmacy combinations containing benzoxazine for the treatment of respiratory diseases
ZA200701584B (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
GB0709512D0 (en) Disposable inhaler
EP1742641A4 (en) METHODS AND COMPOSITIONS FOR DETECTION AND TREATMENT OF RETINA DISEASES
IL190338A0 (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
IL180931A0 (en) Medicaments for treating chronic respiratory disease
PL1817282T3 (pl) Pochodne kwasu fenoksyoctowego użyteczne do leczenia chorób układu oddechowego
IL185444A0 (en) Novel drugs for treating respiratory diseases
GB0410399D0 (en) The treatment of respiratory disease
GB0410398D0 (en) The treatment of respiratory disease
EP1806148A4 (en) THERAPEUTIC PREPARATION FOR INHALATION
IL197125A0 (en) Drug combinations for treating airway diseases
GB0403370D0 (en) Device for preventing retinal diseases
EP1755635A4 (en) TREATMENT OF INFLAMMATORY RESPIRATORY DISEASE
GB0701456D0 (en) Treatment for respiratory disease
EP2059238A4 (en) THERAPEUTIC COMPOUNDS FOR DISEASES AND DISORDERS
GB0425854D0 (en) Therapeutic treatment
ZA200606780B (en) Compounds for the treatment of diseases
SI1927353T1 (sl) Zdravilo za bolezni roženice
GB0520152D0 (en) Treatment of respiratory disease
GB0420867D0 (en) Compounds for the treatment of diseases
IL177531A0 (en) Compounds for the treatment of diseases
GB0425073D0 (en) Compounds for the treatment of diseases
ZA200804944B (en) Use of a disinfectant for treating respiratory tract infections